| Female | Male | Inter. | ||||
---|---|---|---|---|---|---|---|
HR* | 95% CI | P | HR* | 95% CI | P | P †| |
Demographics | Â | Â | Â | Â | Â | Â | Â |
Age <50 | 0.7 | (0.4–1.1) | 0.087 | 0.4 | (0.3–0.6) | <0.001 | 0.076‡ |
Age >70 | 2.5 | (2.0–3.1) | <0.001 | 2.9 | (2.5–3.3) | <0.001 | 0.17 |
Heart disease | Â | Â | Â | Â | Â | Â | Â |
History of MI | 1.8 | (1.4–2.3) | <0.001 | 1.7 | (1.5–2.0) | <0.001 | 0.99 |
LVEF <40% | 1.3 | (1.1–1.6) | 0.018 | 1.7 | (1.5–2.0) | <0.001 | 0.018‡ |
Killip class II–IV | 2.1 | (1.7–2.6) | <0.001 | 2.1 | (1.8–2.4) | <0.001 | 0.41 |
Beta-blocker use | 0.7 | (0.6–0.9) | 0.001 | 0.8 | (0.7–0.9) | 0.001 | 0.72 |
Comorbidity | Â | Â | Â | Â | Â | Â | Â |
Diabetes | 1.8 | (1.4–2.2) | <0.001 | 1.7 | (1.5–2.0) | <0.001 | 0.89 |
Depression low | 0.8 | (0.6–1.1) | 0.27 | 0.9 | (0.7–1.0) | 0.13 | 0.67 |
Depression high | 1.1 | (0.9–1.4) | 0.41 | 1.4 | (1.2–1.6) | <0.001 | 0.054‡ |
Antidepressant use | 1.2 | (0.8–1.6) | 0.37 | 1.3 | (1.1–1.7) | 0.017 | 0.36 |
General health | Â | Â | Â | Â | Â | Â | Â |
Hyperlipidaemia | 1.0 | (0.8–1.2) | 1.0 | 0.8 | (0.7–1.0) | 0.037 | 0.26‡ |
Smoking | 0.9 | (0.7–1.2) | 0.54 | 1.2 | (1.0–1.4) | 0.068 | 0.48 |
BMI <20 | 1.4 | (1.0–2.1) | 0.071 | 1.3 | (0.9–1.8) | 0.14 | 0.91 |
BMI >30 | 0.9 | (0.7–1.1) | 0.33 | 0.9 | (0.7–1.1) | 0.19 | 0.64 |